Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence

  • Coronary Heart Disease (E Gianos and B Shah, Section Editor)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Type 2 myocardial infarction (type 2 MI) is defined as myocardial necrosis that results from an imbalance of myocardial oxygen supply and demand. Although type 2 MI is highly prevalent and strongly associated with mortality, the pathophysiology remains poorly understood. Discrepancies in definitions, frequency of screening, diagnostic approaches, and methods of adjudication lead to confusion and misclassification. To date, there is no consensus on the diagnostic criteria for type 2 MI. No guidelines exist for the optimal management of this condition, and further investigation is urgently needed. This review explores the existing evidence on the pathophysiology, diagnosis, prognosis, and management of type 2 MI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197–204.

    Article  CAS  PubMed  Google Scholar 

  2. Landesberg G, Vesselov Y, Einav S, Goodman S, Sprung CL, Weissman C. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med. 2005;33:1281–7.

    Article  CAS  PubMed  Google Scholar 

  3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98. This preference provides the accepted modern definition of myocardial infarction and defines the 5 major subtypes.

    Article  PubMed  Google Scholar 

  4. Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin i in sepsis and septic shock. Intensive Care Med. 2001;27:965–9.

    Article  CAS  PubMed  Google Scholar 

  5. Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR. Cardiac troponin i predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol. 2004;95:13–7.

    Article  PubMed  Google Scholar 

  6. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins i and t are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000;46:650–7.

    Google Scholar 

  7. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;26:31–7.

    Article  CAS  PubMed  Google Scholar 

  8. Vasile VC, Babuin L, Rio Perez JA, Alegria JR, Song LM, Chai HS, et al. Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med. 2009;37:140–7.

    Article  CAS  PubMed  Google Scholar 

  9. Iser DM, Thompson AJ, Sia KK, Yeomans ND, Chen RY. Prospective study of cardiac troponin i release in patients with upper gastrointestinal bleeding. J Gastroenterol Hepatol. 2008;23:938–42.

    Article  PubMed  Google Scholar 

  10. Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S. Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med Wkly. 2003;133:439–41.

    CAS  PubMed  Google Scholar 

  11. Bukkapatnam RN, Robinson M, Turnipseed S, Tancredi D, Amsterdam E, Srivatsa UN. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol. 2010;106:374–7.

    Article  PubMed  Google Scholar 

  12. Chow GV, Hirsch GA, Spragg DD, Cai JX, Cheng A, Ziegelstein RC, et al. Prognostic significance of cardiac troponin i levels in hospitalized patients presenting with supraventricular tachycardia. Medicine. 2010;89:141–8.

    Article  CAS  PubMed  Google Scholar 

  13. Pattanshetty DJ, Bhat PK, Aneja A, Pillai DP. Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis: a retrospective study. J Hypertens. 2012;30:2410–5.

    Article  CAS  PubMed  Google Scholar 

  14. Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, et al. Type-ii myocardial infarction–patient characteristics, management and outcomes. PLoS One. 2014;9:e84285.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126:789–97. This reference outlines general clinical characteristics of patients who develop Type 2 myocardial infarction and provides a set of definitions for conditions predisposing to mismatch in myocardial oxygen supply and demand.

    Article  PubMed  Google Scholar 

  16. McFalls EO, Larsen G, Johnson GR, Apple FS, Goldman S, Arai A, et al. Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med. 2011;124:630–5. This is the largest study to evaluate long-term outcomes in patients with positive troponins associated with non-acute coronary syndrome conditions.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Saaby L, Poulsen TS, Diederichsen AC, Hosbond S, Larsen TB, Schmidt H, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med. 2014;127:295–302.

    Article  PubMed  Google Scholar 

  18. Javed U, Aftab W, Ambrose JA, Wessel RJ, Mouanoutoua M, Huang G, et al. Frequency of elevated troponin i and diagnosis of acute myocardial infarction. Am J Cardiol. 2009;104:9–13.

    Article  CAS  PubMed  Google Scholar 

  19. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med. 2006;166:2446–54.

    Article  CAS  PubMed  Google Scholar 

  20. Wu TT, Yuan A, Chen CY, Chen WJ, Luh KT, Kuo SH, et al. Cardiac troponin i levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the apache ii score in outcome prediction. Shock. 2004;22:95–101.

    Article  CAS  PubMed  Google Scholar 

  21. Quenot JP, Le Teuff G, Quantin C, Doise JM, Abrahamowicz M, Masson D, et al. Myocardial injury in critically ill patients: relation to increased cardiac troponin i and hospital mortality. Chest. 2005;128:2758–64.

    Article  CAS  PubMed  Google Scholar 

  22. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008;36:759–65.

    Article  CAS  PubMed  Google Scholar 

  23. Wright RS, Williams BA, Cramner H, Gallahue F, Willmore T, Lewis L, et al. Elevations of cardiac troponin i are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol. 2002;90:634–6.

    Article  CAS  PubMed  Google Scholar 

  24. Vasile VC, Chai HS, Abdeldayem D, Afessa B, Jaffe AS. Elevated cardiac troponin t levels in critically ill patients with sepsis. Am J Med. 2013;126:1114–21.

    Article  CAS  PubMed  Google Scholar 

  25. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation. 2009;119:2936–44.

    Article  PubMed  Google Scholar 

  26. Oberweis BS, Nukala S, Rosenberg A, Guo Y, Stuchin S, Radford MJ, et al. Thrombotic and bleeding complications after orthopedic surgery. Am Heart J. 2013;165:427–33. e421.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study I, Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295–304.

    Article  CAS  PubMed  Google Scholar 

  28. Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154:523–8.

    Article  CAS  PubMed  Google Scholar 

  29. Melberg T, Burman R, Dickstein K. The impact of the 2007 esc-acc-aha-whf universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol. 2010;139:228–33.

    Article  PubMed  Google Scholar 

  30. Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, et al. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. 2009;119:2758–64.

    Article  CAS  PubMed  Google Scholar 

  31. Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the triton-timi 38 trial (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Circulation. 2012;125:577–83.

    Article  PubMed  Google Scholar 

  32. Ambrose JA, Loures-Vale A, Javed U, Buhari CF, Aftab W. Angiographic correlates in type 1 and 2 mi by the universal definition. J Am Coll Cardiol Img. 2012;5:463–4.

    Article  Google Scholar 

  33. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol. 2003;41:2004–9.

    Article  CAS  PubMed  Google Scholar 

  34. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142:786–91.

    Article  PubMed  Google Scholar 

  35. Logeart D, Beyne P, Cusson C, Tokmakova M, Leban M, Guiti C, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J. 2001;141:247–53.

    Article  CAS  PubMed  Google Scholar 

  36. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. The coronary circulation in human septic shock. Circulation. 1986;73:637–44.

    Article  CAS  PubMed  Google Scholar 

  37. Altmann DR, Korte W, Maeder MT, Fehr T, Haager P, Rickli H, et al. Elevated cardiac troponin i in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One. 2010;5:e9017.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Januzzi Jr JL, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third universal definition of myocardial infarction global task force: heart failure section. Eur Heart J. 2012;33:2265–71.

    Article  CAS  PubMed  Google Scholar 

  39. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O’Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;56:1071–8.

    Article  CAS  PubMed  Google Scholar 

  40. Shah RV, Chen-Tournoux AA, Picard MH, Januzzi JL. Association between troponin t and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function. Eur J Echocardiogr: J Work Group Echocardiogr Eur Soc Cardiol. 2009;10:765–8.

    Article  Google Scholar 

  41. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107:1375–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003;361:1787–9.

    Article  CAS  PubMed  Google Scholar 

  43. Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin t in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30:1354–9.

    Article  CAS  PubMed  Google Scholar 

  44. Landesberg G. Monitoring for myocardial ischemia. Best Prac Res Clin Anaesthesiol. 2005;19:77–95.

    Article  Google Scholar 

  45. Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127:105–8.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Nathaniel R. Smilowitz, Becky Naoulou, and Steven P. Sedlis declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY, USA

    Nathaniel R. Smilowitz, Becky Naoulou & Steven P. Sedlis

  2. New York Harbor Health Care System, Veteran Affairs Hospital, New York, NY, USA

    Steven P. Sedlis

Authors
  1. Nathaniel R. Smilowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Becky Naoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven P. Sedlis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven P. Sedlis.

Additional information

This article is part of the Topical Collection on Coronary Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smilowitz, N.R., Naoulou, B. & Sedlis, S.P. Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence. Curr Atheroscler Rep 17, 4 (2015). https://doi.org/10.1007/s11883-014-0478-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-014-0478-1

Keywords

Search

Navigation